Abstract: The present invention provides compounds of the formula (I):, or a pharmaceutically acceptable salt thereof, wherein A, X1, X2, X3, Y, Z, Z1, Z2, R2 and R6 are as defined herein, for use in the treatment of cancer and a method of treating cancer.
| # | Name | Date |
|---|---|---|
| 1 | 202417080526-STATEMENT OF UNDERTAKING (FORM 3) [23-10-2024(online)].pdf | 2024-10-23 |
| 2 | 202417080526-PRIORITY DOCUMENTS [23-10-2024(online)].pdf | 2024-10-23 |
| 3 | 202417080526-POWER OF AUTHORITY [23-10-2024(online)].pdf | 2024-10-23 |
| 4 | 202417080526-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [23-10-2024(online)].pdf | 2024-10-23 |
| 5 | 202417080526-MARKED COPIES OF AMENDEMENTS [23-10-2024(online)].pdf | 2024-10-23 |
| 6 | 202417080526-FORM 18 [23-10-2024(online)].pdf | 2024-10-23 |
| 7 | 202417080526-FORM 13 [23-10-2024(online)].pdf | 2024-10-23 |
| 8 | 202417080526-FORM 1 [23-10-2024(online)].pdf | 2024-10-23 |
| 9 | 202417080526-FIGURE OF ABSTRACT [23-10-2024(online)].pdf | 2024-10-23 |
| 10 | 202417080526-DECLARATION OF INVENTORSHIP (FORM 5) [23-10-2024(online)].pdf | 2024-10-23 |
| 11 | 202417080526-COMPLETE SPECIFICATION [23-10-2024(online)].pdf | 2024-10-23 |
| 12 | 202417080526-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [23-10-2024(online)].pdf | 2024-10-23 |
| 13 | 202417080526-AMMENDED DOCUMENTS [23-10-2024(online)].pdf | 2024-10-23 |
| 14 | 202417080526-Proof of Right [14-04-2025(online)].pdf | 2025-04-14 |
| 15 | 202417080526-FORM 3 [15-04-2025(online)].pdf | 2025-04-15 |